Cancer and COVID-19 Resources
The Board of the European Cancer Organisation has agreed to launch a Special Network on the impact of COVID-19 on Cancer, on a “task and finish” basis to be co-chaired by Board members Mirjam Crul and Mark Lawler. Read more here.
During this unprecedented crisis, our Member Societies, Patient Advisory Committee and wider network in the European cancer community are sharing information and experience through this webpage. If you have documents or links to share from your organisation, please contact us here.
The Board of Directors of the European Cancer Organisation has released the following Statement on the ongoing measures being taken across Europe to manage the developing situation connected to the COVID-19 pandemic. The Statement gives particular attention to the growing impact of COVID-19 upon the treatment of cancer patients, as well as the impact of the present situation upon the functioning of Europe’s scientific, healthcare professional education and patient association sector.
Association of European Cancer Leagues (ECL)
- COVID-19: Open Letter
- ECL COVID-19 online hub
-
ECL Call for Action: Ensuring cancer prevention and care in times of COVID-19
Cardiovascular and Interventional Radiological Society of Europe (CIRSE)
European Association of Nuclear Medicine (EANM)
European Association for Palliative Care (EAPC)
European Association of Urology (EAU)
European Oncology Nursing Society (EONS)
European Organisation for Research and Treatment of Cancer (EORTC)
European Pain Federation (EFIC)
European Respiratory Society (ERS)
European Society of Coloproctology (ESCP)
European Society of Gynaecological Cancer (ESGO)
- Leadership Statement on COVID-19
- ENGOT Recommendations of Conduct of Clinical Trials During the COVID-19 Pandemic
- ESGO Webinar on Management of Ovarian Cancer during the COVID-19 Pandemic, 8 March 2020, 6 pm CEST
European School of Oncology (ESO)
European Society of Oncology Pharmacy (ESOP)
European Society of Pathology (ESP)
European Society of Radiology (ESR)
- COVID-19 Epidemic Crisis – ESR Calls for Strengthened Approach Safeguarding Public Health and Guaranteeing Legal Certainty Across Member States
- COVID-19 Online Resource Hub
European SocieTy for Radiotherapy and Oncology (ESTRO)
European Society of Surgical Oncology (ESSO)
European Society for Paediatric Oncology (SIOP Europe)
International Society of Geriatric Oncology (SIOG)
Multinational Association of Supportive Care in Cancer (MASCC)
European Cancer Patient Coalition
European Breast Cancer Coalition (Europa Donna)
International Brain Tumour Alliance (IBTA)
- COVID-19 Announcement
- COVID-19 Information for the International Brain Tumour Community
- International Survey: “COVID-19: the brain tumour patient and caregiver experience”.
The deadline for completing the survey is 30 April 2020.
Lung Cancer Europe (LuCE)
-
Cancer and COVID-19: How do we Manage Cancer Optimally through a Public Health Crisis?
-
Clinical Impact of COVID-19 on Patients with Cancer (CCC19): A Cohort Study
-
Coronavirus (COVID-19) Information and Research at Queen's University Belfast
-
COVID-19 Mortality in Patients with Cancer on Chemotherapy or Other Anticancer Treatments: A Prospective Cohort Study
-
ESMO Guidelines on Cancer Patient Management During the COVID-19 Pandemic
-
ESMO Management and Treatment Adapted Recommendations in the COVID-19 Era: Breast Cancer
-
Is Low Dose Radiation Therapy a Potential Treatment for COVID-19 Pneumonia?
-
Recommendations for Triage, Prioritization and Treatment of Breast Cancer Patients During the COVID-19 Pandemic
-
Running a Radiation Oncology Department at the Time of Coronavirus: An Italian Experience
-
The American Society of Breast Surgeons Recommendations for Prioritization, Treatment and Triage of Breast Cancer Patients During the COVID-19 Pandemic: Executive Summary
-
The Coronavirus Outbreak and Management of Breast Cancer Patients
-
The Coronavirus Pandemic in Israel: Implications for Radiation Oncology Departments
